Novavax, JNJ dispute pre-payments for canceled COVID shots sought for world’s poor - NYT

Feb. 01, 2023 11:18 AM ETNovavax, Inc. (NVAX), JNJMRNABy: Dulan Lokuwithana, SA News Editor67 Comments

A conceptual image of a world globe map with vials for the global SARS/COVID pandemic vaccine war, with vaccine hoarding, restricting equal access to vaccines across the world, caused by vaccine nationalism and lack of vaccine solidarity


Novavax (NASDAQ:NVAX) and Johnson & Johnson (NYSE:JNJ) are locked in a bitter dispute over advance payments made for millions of COVID-19 vaccine doses the companies agreed to deliver to low-income countries but later canceled,

Recommended For You

Comments (67)

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.